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The incubation of 15â-hydroxy-3-oxo-ent-kaur-16-ene (1) with the fungus Gibberella fujikuroi afforded
11â-hydroxy-3,15-dioxo-ent-kaurane (6), 11â,15â-dihydroxy-3-oxo-ent-kaur-16-ene (8), 7â,11â,15â-trihy-
droxy-3-oxo-ent-kaur-16-ene (9), 7R,11â-dihydroxy-3,15-dioxo-ent-kaurane (7), and 7R,11â,15â-trihydroxy-
3-oxo-ent-kaur-16-ene (10). The incubation of 15â-hydroxy-ent-kaur-2,16-diene (3) with the same fungus
yielded 7R,11â-dihydroxy-15-oxo-ent-kaur-2-ene (12), 7R,11â,15â-trihydroxy-ent-kaur-2,16-diene (13), 7â,-
15â-dihydroxy-ent-kaur-2,16-dien-19,6-olide (14), 1â,7â,15â-trihydroxy-ent-kaur-2,16-dien-19-oic acid (15),
7R,11â,16R-trihydroxy-15-oxo-ent-kaur-2-ene (17), and 7R,15â,17-trihydroxy-11â,16â-epoxy-ent-kaur-2-
ene (19). These results indicated that a 3-oxo group in ent-kaur-16-ene derivatives inhibits the oxidation
at C-19, typical of the biosynthetic pathway of gibberellins and kaurenolides, while a 2,3-double bond or
a 15â-OH does not. In both substrates a 15â-alcohol directs hydroxylations at C-11(â) and C-7(R), while
in those with a 2,3-double bond the functionalization of C-1(â) is favored.
For several years we have studied the biotransformation
of ent-kaurene diterpenes by the fungus Gibberella fujikuroi.
The main aims of these works have been to prepare new
gibberellin analogues, to study the biosynthetic pathway
of these plant hormones, and to obtain information about
the substrate specificity of the enzymes involved in the
biosynthesis of gibberellins and kaurenolides. We have
shown that in ent-kaurene derivatives a 15R-hydroxyl
group,1,2 a 16R-alcohol,3 or a 15R,16R-epoxide4 directs
hydroxylation at C-11(â) and C-7(R) and inhibits oxidation
at C-19. This oxidation is typical of the biosynthetic route
of gibberellins.5 We have also studied the microbial trans-
formation of 3R,15â-dihydroxy derivatives by this fungus.6
In the latter neither gibberellins nor kaurenolides were
obtained due to the presence of the 3R-hydroxyl group in
the molecule, which also inhibits the oxidation at C-19. We
have also shown that ent-kaurene diterpenes with a 15-
oxo7 or a 15â,18-dihydroxyl8 group can be oxidized at C-19
at the acid level and biotransformed all along the gibber-
ellin and kaurenolide pathway. Here, we report the results
obtained in the incubation with G. fujikuroi of two 15â-
hydroxy-kaurene diterpenes, 1 and 3, which are not hy-
droxylated at C-19 and possess a 3-oxo group and a 2,3-
double bond, respectively.
Results and Discussion
The substrates 1 and 3 were prepared as follows: (a)
3R-Hydroxy-15â-angeloxy-ent-kaur-16-ene (5) was oxidized
with Jones reagent to give 2, which was hydrolyzed with
methanolic potassium hydroxide, affording 3-oxo-15â-hy-
droxy-ent-kaur-16-ene (1). (b) Dehydration of 5 with phos-
phorus oxychloride led to 4, which was hydrolyzed, giving
15â-hydroxy-ent-kaur-2,16-diene (3).9 The starting com-
pound in both preparations (5) had been isolated from
Elaseolinum tenuifolium.9,10
The biotransformations with the fungus were carried out
in the presence of AMO 1618, a compound that inhibits
the production of ent-kaur-16-ene without affecting the
post-kaurene metabolism.11,12 The substrates were incu-
bated with G. fujikuroi in two different experiments, and
the cultures were extracted following the usual procedure.
Chromatography of the extract obtained in the incuba-
tion of 1 afforded 6-10. The least polar metabolite 6
showed a molecular ion at m/z 318.2185 in accordance with
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the molecular formula C20H30O3. In its 1H and 13C NMR
spectra it was observed that the exocyclic double bond and
the 15â-alcohol of the substrate had disappeared, being
replaced by a carbonyl (äC 222.3) and a methyl group (äH
1.27, d, J ) 6.8 Hz, äC 11.1). Thus, the formation of a 15-
oxo,17-methyl derivative had occurred during the fermen-
tation. The 1H NMR spectrum also showed a new hydrogen
signal at ä 3.94 (d, J ) 5.5 Hz). Its chemical shift, the form
of the signal, and the coupling constant were characteristic
of a hydrogen geminal to an alcohol group at C-11(â) in
ent-kaur-16-ene diterpenes.1,2 The results of a 2D NMR
study (COSY, HSQC, and HMBC) were in accordance with
these assertions and permitted us to assign the structure
of 11â-hydroxy-3,15-dioxo-ent-(16S)-kaurane (6) to this
substance. The formation of this 15-oxo,17-methyl deriva-
tive implies a rearrangement, produced by protonation of
the 16,17-double bond with formation of a 16-carbocation
and a 15,16-hydride shift, because this type of rearrange-
ment occurs very readily in acid medium.13 Another pos-
sibility is that compound 6 could be formed by oxidation of
the 15â-OH and subsequent hydrogenation of the 15,16-
double bond, because we have shown that G. fujikuroi
transforms 15-oxo-ent-kaur-16-ene derivatives into the
corresponding dihydroderivatives.7 The â-stereochemistry
assigned to the 17-methyl was given considering that both
reactions, 15,16-hydride shift and hydrogenation of the
16,17-double bond, take place by the R-face.7,13,14
The second metabolite isolated (8) had a molecular
formula C20H30O3 as determined by HRMS, which indicated
that a new oxygen had been introduced into the molecule
during the fermentation. Its 1H NMR spectrum showed a
proton geminal to a new alcohol group resonating as a
doublet at ä 4.00 (J ) 4.8 Hz), which was assigned to C-11-
(â). This was confirmed by its 13C NMR spectrum (Table
1), which was unambiguously assigned by two-dimensional
NMR analysis. Therefore, the structure of this compound
was determined to be 11â,15â-dihydroxy-3-oxo-ent-kaur-
16-ene (8). This compound had been isolated from Rabdosia
inflexa and named inflexarabdonin J.15
The third substance obtained from this incubation was
9. Its HRMS was in accordance with the formula C20H30O4.
The 1H NMR spectrum was very similar to that of 8, but
now the signal of a proton geminal to a new alcohol
appeared at ä 3.81 (t, J ) 3 Hz). Its coupling constant
indicated that the hydroxyl group must be axial and
situated at C-1(â) or C-7(â). The latter position was chosen
considering its HMBC spectrum, where correlations of H-7
with C-5 and C-15 were observed. Thus, the structure 7â,-
11â,15â-trihydroxy-3-oxo-ent-kaur-16-ene (9) was assigned
to this compound.
Another metabolite was identified as 7R,11â,15â-trihy-
droxy-3-oxo-ent-kaur-16-ene (10) as follows. The molecular
ion at 334.2139 indicated a C20H30O4 molecular formula.
Its 1H NMR spectrum, in comparison with that of the
substrate, showed two new hydrogens at ä 3.72 (dd, J )
11.6 and 4.3 Hz) and 4.00 (d, J ) 4.9 Hz). The coupling
constants for the first of these signals were typical of a
proton geminal to an equatorial alcohol group at C-1(R) or
C-7(R). The 7R-position was chosen considering the 13C
NMR data (Table 1). The second of these signals was
assigned to the proton geminal to an 11â-hydroxyl by
comparison with the 1H and 13C NMR spectra of compounds
such as 8 and 9. A study of the HMQC and HMBC spectra
confirmed the structure of 10.
An isomer of 10, with structure 7, was also isolated from
this incubation. Its 1H NMR spectrum showed, as in the
case of 6, that during the incubation a rearrangement of
ring D had occurred. Thus, the proton geminal to the 15â-
OH and the hydrogens of the 16,17-double bond of the
substrate were not observed, being substituted by a C-17
methyl (ä‚ 1.26, d, J ) 6.9 Hz; äC 11.1) and a 15-oxo group
(ä 221.7). The hydrogen geminal to the 7R- and 11â-alcohol
appeared at ä 3.93 (dd, J ) 11.6 and 4.3 Hz) and 4.00 (d,
J ) 4.9 Hz), respectively. The chemical shifts and splitting
patterns of these protons were similar to those of its isomer
10 and to those of other compounds with these oxygen
functions.7 Correlations between the H-7 and the 15-oxo
group and of H-11 with C-9 were observed in the HMBC
spectrum. Therefore, the structure of this compound was
determined to be 7R,11â-dihydroxy-3,15-dioxo-ent-(16S)-
kaurane (7).
The second incubation with G. fujikuroi was carried out
with substrate 3. In comparison with 1, the 3-oxo group of
1, inhibitor of the oxidation at C-19, has been substituted
by a 2,3-double bond in 3. This biotransformation yielded
the metabolites 12-15, 17, and 19. A compound hydroxyl-
ated at C-15(â) and C-19 had been previously incubated
with this fungus, giving 1â- and 6â-hydroxy derivatives
with C-19 in the form of an acid group.16
The arguments used above in the assignment of the
alcohol groups at C-7(R) and C-11(â) in metabolites 7 and
10 were the same ones utilized to locate them in substances
12 and 13, respectively. Compound 18 was obtained when
13 was left in CDCl3 in a NMR tube for four weeks.
Substance 18 appears to be formed from 13 by protonation
of the 16,17-double bond in the acid medium and neutral-
ization of the ion created at C-16 by 11â-OH. Their 1H and
13C NMR spectra showed H-11 at ä 4.24 (br s) and 84.2,
respectively. These chemical shifts and forms of resonance
are characteristic of this type of compound.3,6
Another substance obtained from this experiment was
7â,15â-dihydroxykaurenolide (14) (C20H24O3). The 1H NMR
spectrum showed that ring B contained the vicinal 6R,7â-
oxygen functions characteristic of similar lactones (ä 4.42,
d, J ) 6.5 Hz, H-7; 4.77, t, J ) 6.5 Hz, H-6; 2.28, d, J ) 6.5
Hz, H-5). The H-15 signal appeared as a broad singlet at ä
4.68. 13C NMR showed the corresponding carbons at 71.4
(C-7), 83.3 (C-6), 50.6 (C-5), and 73.2 (C-15), and the oxo
group of C-19 appeared at ä 178.0.
Compound 15 was obtained as its triacetate methyl ester
16a by methylation of the extract and subsequent acetyl-
ation of the chromatographic fractions containing it. Its 1H
NMR spectrum showed, in comparison with those of the
Table 1. 13C NMR Data (ä) for Compounds 1 and 6-10
C 1 6 7 8 9 10
1 39.2 38.1 37.7 38.8 38.9 38.5
2 34.1 33.5a 33.8a 33.8 33.7a 33.7
3 218.6 217.0 216.4 217.7 217.8 216.9
4 47.1 47.1 46.9 47.0 46.4b 46.8
5 53.9 53.4 50.3 53.54 44.1 50.6
6 21.1 19.8 29.0 21.0 28.1 26.9
7 37.8 33.6a 71.0 37.8 76.9 71.1
8 45.5 50.7 56.7 44.4 46.6b 49.7
9 45.3 62.0 61.1 53.4 49.2 52.4
10 38.1 37.3 36.9 36.6 36.4 36.7
11 18.6 65.3 65.3 67.1 66.4 67.0
12 33.0 33.2a 33.4a 43.0 43.1 43.5
13 40.0 34.6 34.0 38.8 38.9 38.5
14 36.0 36.9 28.3 35.4 33.6a 30.3
15 82.2 222.3 221.7 82.3 82.0 75.6
16 157.9 49.5 51.0 157.9 155.7 157.4
17 105.1 11.1 11.1 106.3 106.8 106.7
18 27.2 27.3 27.3 27.5 27.4 27.4
19 21.0 20.8 20.8 20.8 20.8 20.8
20 17.7 17.8 18.0 18.0 18.3 18.0
a,b These values can be interchanged.
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substrate, the signals of a methyl ester at ä 3.61 and of
two new geminal protons to acetoxy groups at ä 4.78 (br s)
and 5.07 (d, J ) 5.4 Hz). The last one was assigned to
C-1(â) by a double radiation experiment. Irradiation of H-1
at ä 5.07 converted the double doublet of H-2 at 5.76 into
a clean doublet. Alternatively, irradiation of this last signal
transformed the doublet of H-1 into a singlet. Unambiguous
assignment of the 13C NMR data (Table 2), using HMQC
and HMBC spectra, confirmed the position of this acetoxy
group and permitted us to place the other acetate at C-7(â)
and the methyl ester at C-19. The â-stereochemistry for
the acetate at C-1 was determined considering the coupling
constant (5.4 Hz) observed between H-1(R) and H-2 in the
conformer of less energy, which was obtained by MM+
molecular mechanics calculations. Therefore, the structure
of the corresponding compound formed in the incubation
was determined to be 1â,7â,15â-trihydroxy-ent-kaur-2,16-
diene-19-oic acid (15).
The structure of 7R,11â,16R-trihydroxy-15-oxo-ent-kaur-
2-ene (17) was assigned to another substance from this
fermentation. Its 1H NMR spectrum was very similar to
that of 12, except that in 17 the C-17 methyl appeared as
a singlet at ä 1.33, indicating the presence in C-16 of a
hydroxyl group, which was also in accordance with the
corresponding carbon resonance (ä 77.7) and with the
molecular formula C20H30O4 (m/z 334.2137). The stereo-
chemistry assigned to the 16R-alcohol was given consider-
ing that in this kind of molecule the hydroxylation normally
occurs by the R-face.17
The 1H NMR spectrum of compound 19 (C20H30O4)
showed three methyls, a hydroxymethylene group, and
three protons geminal to oxygenated functions. The disap-
pearance of the exocyclic double-bond hydrogens in this
spectrum and the absence of the oxo carbon resonances
indicated the existence of an ether bridge between C-11(â)
and C-16(â). This was confirmed by the resonance of H-11
at ä 4.32, whose chemical shift and splitting pattern are
characteristic of this grouping.3 The other two geminal
hydrogens were overlapped in the 1H NMR spectrum. One
was assigned to C-15(â) considering that it is present in
the substrate and the other at C-7(R) considering its 13C
resonance at ä 69.3, which was similar to that observed in
18 (ä 69.7). The hydroxymethylene group was located at
C-17 observing the chemical shift of C-16, ä 84.2 and 86.7,
in 18 and 19, respectively. Thus, 19 was determined to be
7R,15â,17-trihydroxy-11â,16â-epoxy-ent-kaur-2-ene. This
was confirmed by the correlations observed in the HMBC
spectrum of H-17 with C-16 and C-13, of H-13 with C-14
and C-11, and of H-12 with C-14 and C-16. Substance 19
must be an artifact, probably formed in the medium from
20 by acid opening of the 16R,17R-epoxide with attack over
C-16 of the 11â-OH. The oxirane ring in 20 has an
R-stereochemistry because the microbiological epoxidation
of ent-kaurene derivatives occurs via the R-face.2,18 The
â-stereochemistry to the ether bridge in 19 was assigned
considering the 11â-alcohol attack at C-16 by the â-face,
also favored by the R-opening of the epoxy ring.
The results of these two biotransformations may be
summarized as follows:
1. The existence of a 15â-hydroxyl group in the molecule
does not inhibit the oxidation at C-19, typical of the
biosynthetic pathway of gibberellins and kaurenolides, in
contrast with our previous studies that showed that its
epimer, a 15R-alcohol, inhibits oxidation thereof.
2. The presence of a 15â-alcohol directs the hydroxylation
at C-11(â) and C-7(R). Similar results were obtained by us
with 15R-alcohols1,2 and 15-oxo ent-kaur-16-ene7 deriva-
tives.
Table 2. 13C NMR Data for Compounds 3, 12, 14, 16a, and
17-19
C 3 12 14 16a 17 18 19
1 41.2 40.0 39.5 70.7 40.1 40.9 40.9
2 121.4 120.4 122.7 122.1 120.3 120.8 120.7
3 137.7 138.0 127.6 136.1 138.1 137.4 137.4
4 34.7 34.6 43.6 44.9 34.7 34.3 34.3
5 51.3 48.9 50.6 39.9 48.9 49.2a 48.9
6 20.8 28.4a 83.3 25.9 28.2 29.6 29.5
7 35.9 71.1 71.4 78.2 70.8 69.7 69.3
8 45.7 57.1 47.4 47.3 57.0 50.0 50.3
9 44.9 61.3 43.8 32.5 63.2 48.8a 49.8
10 37.6 36.5 33.9 40.5 36.7 35.0 35.0
11 18.4 65.2 16.6 17.8 65.4 76.5b 76.8
12 33.3 33.7 33.1 33.2 36.4 39.1 39.5
13 40.1 34.1 36.0 40.5 40.9 41.3 38.2
14 37.9 28.6a 28.9 35.4 25.1 29.6 29.5
15 82.5 222.0 73.2 79.0 220.0 76.6b 73.7
16 158.1 50.4 161.4 153.2 77.7 84.2 86.7
17 104.9 11.1 107.6 107.4 19.5 20.2 63.7
18 31.8 31.6 24.7 26.9 31.7 31.8 31.8
19 22.5 22.3 178.0 175.1 22.4 22.6 22.6
20 17.9 18.2 18.2 16.0 18.3 18.8 18.8
a ,bThese values can be interchanged.
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3. A 3-oxo group in the molecule inhibits oxidation at
C-19. This had also occurred when there was a 3R-alcohol1,2
but not when a 3â-ˆ‚ was present.19
4. The presence of a 2,3-double bond does not affect the
oxidation at C-19.
5. In the biotransformation of substrates with a 15â-
hydroxyl and a 2,3-double bond such as 3, there are two
competitive processes, the oxidation at C-19 and the
hydroxylation at C-11(â) and C-7(R). Thus, the amount of
substrate that is oxidized in C-19 to an acid group, a
prerequisite to be transformed into kaurenolides and
gibberellins, is low. Moreover, we have also observed that
there is a preference for the formation of kaurenolides with
respect to gibberellins.
6. Another competitive biotransformation is the hydroxyl-
ation at C-1(â) in the substrate 3 to give 15, which is
directed by the presence of the 2,3-double bond.
7. Isomerization of the 15â-hydroxy to the 15-oxo deriva-
tives seems not to be produced in the medium by acid
rearrangement because compound 11, which should be
obtained from rearrangement of substrate 1, was not
isolated from the fermentation. Thus, this is a biotrans-
formation produced by the fungus by a garryfoline-
cuauchichicine type rearrangement13 or by oxidation of the
15â-alcohol and subsequent hydrogenation of the 16,17-
double bond.
8. The occurrence of 11â-hydroxylated ent-kaur-16-ene
diterpenes with oxygen functions of the 15R-OH, 15â-OH,
or 15-oxo type in liverworts20,21 and higher plants22,23 seems
to indicate that the 11â-hydroxylation should be directed
by the presence in the molecule of a 15-oxygenated sub-
stituent, as occurs in the microbiological transformations
with the fungus G. fujikuroi.
Experimental Section
General Experimental Procedures. Melting points were
determined with a Reichert Thermovar apparatus and are
uncorrected. IR spectra were recorded in a Perkin-Elmer 1600
FT. 1H NMR spectra were recorded in CDCl3 solution at 200.13
and 500.13 MHz with a Bruker AC-200 or a Bruker AMX-500
spectrometer, respectively, and the 13C NMR at 125.03 MHz
in a Bruker AMX-500, except those of 3 and 6-10, which were
recorded at 50 MHz in a Bruker AC-200. Mass spectra were
taken at 70 eV (probe) in a Shimadzu Q2000, and high-
resolution mass spectra in a Micromass Autospec spectrom-
eter. Optical rotations have been measured at 25 °C in a
Perkin-Elmer 343 Plus. HPLC was performed using a Beck-
man System Gold 125P. Purification by HPLC was achieved
using a silica gel column (Ultrasphere Si 5 ím, 10  250 mm).
Dry column chromatography was made on Merck 0.2-0.065
mm silica gel. Molecular mechanics calculations were carried
out with the program Hyperchem 7.0 (Hypercube).
Microorganism. The fungal strain was Gibberella fujikuroi
IMI 58289 and was a gift from Dr. J. R. Hanson, School of
Chemistry, Physics and Environmental Science (University of
Sussex, UK).
Preparation of 15â-Hydroxy-3-oxo-ent-kaur-16-ene (1).
3â-Hydroxy-15â-angeloxy-ent-kaur-16-ene (5) (350 mg), dis-
solved in acetone (20 mL) at 5 °C, was oxidized with Jones
reagent to afford 2.9 The crude extract, dissolved in methanolic
KOH (5%, 15 mL), was heated at 50 °C for 5 h. Usual workup
and column chromatography of the crude mixture, eluting with
petroleum ether-EtOAc (10-1), afforded 1 (210 mg, 76%
overall): colorless crystals; mp 135-136 °C (petroleum ether-
EtOAc); IR (CHCl3) îmax 3593, 3463, 2936, 1698, 1458, 1386
cm-1; 1H NMR (500 MHz) ä 1.03 (3H, s, H-19), 1.07 (1H, m,
H-14), 1.08 (3H, s, H-18), 1.09 (3H, s, H-20), 1.38 (1H, m, H-7),
1.96 (1H, d, J 12.0 Hz, H-14), 2.05 (1H, dt, J ) 13.3 and 6.5
Hz, H-1), 2.47 (2H, dd, J ) 8.5 and 6.4 Hz, H-2), 2.69 (1H, br
s, H-13), 3.80 (1H, t, J ) 2 Hz, H-15), 4.98 and 5.10 (each 1H,
br s, H-17); EIMS m/z (rel int) 302 [M]+ (51), 284 (88), 269
(68), 251 (20), 244 (47), 227 (26), 199 (29); HREIMS m/z [M]+
302.2250 (calcd for C20H30O2, 302.2246); anal. C 79.07%, H
9.66%, calcd for C20H30O2, C 79.42%, H 9.99%.
Preparation of 15â-Hydroxy-ent-kaur-2,16-diene (3).
To 3R-hydroxy-15â-angeloxy-ent-kaur-16-ene (5) (175 mg),
dissolved in dry pyridine (3 mL), was added phosphorus
oxychloride (250 mg). The mixture was stirred overnight at
room temperature and then heated to 80 °C for 4 h. Usual
workup led to 4,9 which was dissolved in methanolic KOH (5%,
7 mL) and heated to 50 °C for 7 h. Purification of the crude
mixture by column chromatography, eluting with petroleum
ether-EtOAc (12:1), afforded 39 (75 mg, 58% overall): 1H NMR
(200 MHz) ä 0.89, 0.96 and 1.09 (each 3H, s), 1.99 (1H, d, J )
11.9 Hz, H-14), 2.15 (1H, dd, J ) 16.9 and 5.3 Hz, H-1), 2.69
(1H, br s, H-13), 3.78 (1H, br s, H-15), 4.98 and 5.10 (each 1H,
br s, H-17), 5.42 (2H, m, H-2 and H-3); EIMS m/z (rel int) 286
[M]+ (6), 271 (3), 253 (8), 228 (6), 204 (4), 171 (5); HREIMS
m/z [M]+ 286.2282 (calcd for C20H30O, 286.2297).
Incubation of 15â-Hydroxy-3-oxo-ent-kaur-16-ene (1).
The fungus G. fujikuroi, inhibited with 5  10-5 M AMO 1618,
was grown on shake culture at 25 °C for 2 days in 55 conical
flasks (250 mL), each containing 50 mL of sterile medium
comprising (per dm3) glucose (80 g), NH4NO3 (0.48 g), KH2-
PO4 (5 g), MgSO4 (1 g), and trace elements solution (2 mL).
The trace elements solution contained (per 100 mL) Co(NO3)2
(0.01 g), CuSO4 (0.015 g), ZnSO4 (0.16 g), MnSO4 (0.01 g), and
(NH4)6Mo7O24 (0.01 g). The substrate 1 (195 mg) dissolved in
EtOH (11 mL) was evenly distributed between the flasks and
the incubation allowed to continue for a further 6 days. The
broth was filtered and the culture filtrate extracted with
EtOAc. The mycelium was treated with liquid nitrogen,
crushed in a mortar, and extracted with EtOAc. Both extracts
were combined, dried over Na2SO4, and concentrated to yield
a syrup (450 mg), which was methylated with diazomethane.
Chromatography on silica gel, eluting with petroleum ether-
ethyl acetate gradient, gave starting material (1) (4 mg), 11â-
hydroxy-3,15-dioxo-ent-(16S)-kaurane (6) (16 mg), 11â,15â-
dihydroxy-3-oxo-ent-kaur-16-ene (8) (10 mg) (inflexarabdonin
J), 7â,11â,15â-trihydroxy-3-oxo-ent-kaur-16-ene (9) (12 mg),
7R,11â-dihydroxy-3,15-dioxo-ent-(16S)-kaurane (7) (26 mg),
and 7R,11â,15â-trihydroxy-3-oxo-ent-kaur-16-ene (10) (11 mg).
The metabolites 6, 8 and 7, 10 were obtained as a pair of
mixtures, which were resolved by chromatography on silica
gel impregnated with AgNO3 (15%) eluting with petroleum
ether-EtOAc (1:1) and EtOAc, respectively.
11â-Hydroxy-3,15-dioxo-ent-(16S)-kaurane (6): colorless
crystals; mp 185-187 °C (petroleum ether-EtOAc), [R]D -82°
(c 0.16, CHCl3); 1H NMR (500 MHz) ä 1.04 (3H, s, H-19), 1.05
(3H, s, H-20), 1.12 (3H, s, H-18), 1.25 (1H, br s, H-9), 1.27 (3H,
d, J ) 6.8 Hz, H-17), 1.65 (1H, dt, J ) 13.5 and 8.5 Hz, H-1â),
2.07 (1H, ddd, J ) 13.5, 7.7 and 5.3 Hz, H-1R), 2.30 (1H, quint,
J ) 6.7 Hz, H-16), 2.34 (1H, dd, J ) 12 and 1.1 Hz, H-14),
2.46 (1 H, ddd, J ) 16, 8.5 and 7.7 Hz, H-2), 2.48 (1H, br s,
H-13), 2.55 (1H, ddd, J ) 16, 8.5 and 5.3 Hz, H-2), 3.94 (1H,
d, J ) 5.5 Hz, H-11); EIMS m/z (rel int) 318 [M]+ (12), 303 (7),
300 (55), 285 (35), 267 (22), 257 (21), 243 (23), 227 (15), 209
(19), 201 (19), 185 (19); HREIMS m/z [M]+ 318.2185 (calcd for
C20H30O3, 318.2195).
7r,11â-Dihydroxy-3,15-dioxo-ent-(16S)-kaurane (7): col-
orless needles; mp 229-232 °C (petroleum ether-EtOAc); [R]D
-111° (c 0.53, CHCl3); 1H NMR (500 MHz) ä 1.05 (6H, s, H-19
and H-20), 1.13 (3H, s, H-18), 1.22 (1H, s, H-9), 1.26 (3H, d, J
) 6.9 Hz, H-17), 1.50 (1H, dt, J ) 12 Hz, H-6R), 1.62 (1H, dt,
J ) 13.3 and 8.5 Hz, H-1), 1.67 (1H, dd, J ) 12 and 2.4 Hz,
H-5), 1.77 (1H, ddd, J ) 12, 4.2, and 2.4 Hz, H-6â), 2.27 (1H,
quint, J ) 6.8 Hz, H-16), 2.47 (1H, dt, J ) 16 and 8.5 Hz,
H-2), 2.52 (1H, br s, H-13), 2.55 (1H, ddd, J ) 16, 8.5, and 5.2
Hz, H-2), 3.93 (1H, d, J ) 5.1 Hz, H-11), 4.00 (1H, dd, J ) 12
and 4.2 Hz, H-7); EIMS m/z (rel int) 334 [M]+ (12), 316 (21),
298 (8), 288 (24), 260 (65), 243 (30), 231 (12), 225 (14), 213
(14), 196 (48), 178 (68); HREIMS m/z [M]+ 334.2140 (calcd for
C20H30O4, 334.2144).
11â,15â-Dihydroxy-3-oxo-ent-kaur-16-ene (inflexarab-
donin J) (8): colorless crystals; mp 170-172 °C (petroleum
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ether-EtOAc); [R]D -80° (c 0.22, CHCl3); 1H NMR (500 MHz)
ä 0.99 (each 3H, s, H-20), 1.04 (3H, s, H-19), 1.11 (3H, s, H-18),
1.14 (1H, m, H-14), 1.68 (1H, br s, H-9), 1.94 (1H, d, J ) 12.1
Hz, H-14), 2.04 (1 H, ddd, J ) 14.6, 5.0, and 2.8 Hz, H-12),
2.09 (1 H, ddd, J ) 13.4, 7.9, and 5.5 Hz, H-1), 2.45 (1H, dt, J
) 16 and 7.9 Hz, H-2), 2.58 (1 H, ddd, J ) 16, 8.4, and 5.5 Hz,
H-2), 2.68 (1 H, br s, H-13), 3.82 (1H, br s, H-15), 4.00 (1H, d,
J ) 4.8 Hz, H-11), 5.05 and 5.14 (each 1H, br s, H-17); EIMS
m/z (rel int) 318 [M]+ (8), 300 (48), 285 (37), 267 (22), 243 (11),
229 (8), 215 (14), 201 (13), 197 (14), 183 (16); HREIMS m/z
[M]+ 318.2215 (calcd for C20H30O3, 318.2195).
7â,11â,15â-Trihydroxy-3-oxo-ent-kaur-16-ene (9): a gum;
1H NMR (500 MHz) ä 0.98 (3H, s, H-20), 1.04 (3H, s, H-19),
1.12 (3H, s, H-18), 1.20 (1H, dd, J ) 12 and 4 Hz, H-14), 1.59
(1 H, dt, J ) 12 and 2 Hz, H-6R), 1.69 (1H, dt, J ) 12 and 3
Hz, H-6â), 1.82 (1H, d, J ) 12 Hz, H-14), 2.37 (1H, dd, J ) 12
and 3 Hz, H-5), 2.42 (1H, dt, J ) 15 and 7.8 Hz, H-2), 2.66
(1H, ddd, J ) 15, 9, and 5.8 Hz, H-2), 2.69 (1H, br s, H-13),
3.81 (1H, t, J ) 3 Hz, H-7), 4.00 (1H, d, J ) 4.7 Hz, H-11),
4.29 (1H, br s, H-15), 5.09 and 5.15 (each 1H, br s, H-17); EIMS
m/z (rel int) 334 [M]+ (79), 316 (50), 303 (96), 298 (81), 283
(44), 270 (28), 265 (24), 255 (27), 227 (22), 209 (24); HREIMS
m/z [M]+ 334.2142 (calcd for C20H30O4, 334.2144).
7r,11â,15â-Trihydroxy-3-oxo-ent-kaur-16-ene (10): col-
orless needles; 190-195 °C (EtOAc); [R]D -85° (c 0.07, CHCl3);
1H NMR (500 MHz) ä 1.01 (3H, s, H-20), 1.06 (3H, s, H-19),
1.13 (3H, s, H-18), 1.56 (1H, t, J ) 12.4 Hz, H-6R), 1.09 (2H,
m, H-1 and H-2), 2.46 (1H, ddd, J ) 15.8 and 7.9 Hz, H-2),
2.59 (1H, ddd, J ) 15.8, 8.5, and 5.5 Hz, H-2), 2.73 (1H, br s,
H-13), 3.72 (1H, dd, J ) 11.6 and 4.3 Hz, H-7), 4.00 (1H, d, J
) 4.9 Hz, H-11), 4.54 (1H, br s, H-15), 5.08 and 5.16 (each 1H,
br s, H-17); EIMS m/z (rel int) 334 [M]+ (25), 316 (34), 298
(64), 288 (25), 283 (44), 280 (36), 265 (23), 255 (20), 241 (18),
213 (41), 195 (44), 181 (46), 165 (48); HREIMS m/z [M]+
334.2139 (calcd for C20H30O4, 334.2144).
Incubation of 15â-Hydroxy-ent-kaur-2,16-diene (3). G.
fujikuroi was grown as above in 55 conical flasks (250 mL).
Substrate 3 (215 mg) dissolved in ethanol (11 mL) was evenly
distributed between the flasks. After 6 days the broth was
filtered and treated as above for 1 to yield a syrup (540 mg).
This extract was treated with diazomethane before purifica-
tion.
Chromatography on silica gel, eluting with petroleum
ether-EtOAc gradient, gave starting material (3) (10 mg), 7R,-
11â-dihydroxy-15-oxo-ent-(16S)-kaur-2-ene (12) (14 mg), 7R,-
11â,15â-trihydroxy-ent-kaur-2,16-diene (13) (3 mg), 7â,15â-
dihydroxy-ent-kaur-2,16-dien-19,6-olide (14) (2 mg), 1â,7â,15â-
trihydroxy-ent-kaur-2,16-diene-19-methylester (16) (4 mg),
7R,11â,16R-trihydroxy-15-oxo-ent-kaur-2-ene (17) (7 mg), and
7R,15â,17-trihydroxy-11â,16â-epoxy-ent-kaur-2-ene (19) (4 mg).
The metabolite 16 was purified as its triacetate 16a.
7r,11â-Dihydroxy-15-oxo-ent-(16S)-kaur-2-ene (12): col-
orless crystals; 242-244 °C; [R]D -91° (c 0.30, CHCl3); 1H NMR
(500 MHz) ä 0.90 (3H, s, H-19), 0.98 (3H, s, H-18), 1.02 (3H, s,
H-20), 1.15 (1H, s, H-9), 1.27 (3H, d, J ) 6.8 Hz, H-17), 1.35
(1H, dd, J ) 12.5 and 2.0 Hz, H-5), 1.44 (1H, dt, J ) 12.5 Hz,
H-6R), 1.71 (1H, d, J ) 16.8 Hz, H-1), 1.79 (1H, ddd, J ) 12.5,
4, and 2 Hz, H-6â), 1.95 (1H, dt, J ) 12 and 4 Hz, H-12), 1.99
(1H, br d, J ) 12 Hz, H-12), 2.01 (2H, br s, H-14), 2.13 (1 H,
m, H-1), 2.26 (1H, quint, J ) 6.8 Hz, H-16), 2.49 (1H, br s,
H-13), 3.94 (1H, d, J ) 5.4 Hz, H-11), 4.02 (1H, dd, J ) 11.7
and 4.1 Hz, H-7), 5.42 (2H, s, H-2 and H-3); EIMS m/z (rel
int) 318 [M]+ (41), 300 (34), 285 (16), 272 (9), 267 (5), 244 (24),
227 (18), 211 (14), 196 (23), 182 (75); HREIMS m/z [M]+
318.2185 (calcd for C20H30O3, 318.2195).
7r,11â,15â-Trihydroxy-ent-kaur-2,16-diene (13): 1H NMR
(200 MHz, CDCl3) ä 0.91 (3H, s, H-19), 0.99 (6H, s, H-18 and
H-20), 2.71 (1H, br s, H-13), 3.68 (1H, dd, J ) 12 and 4.6 Hz,
H-7), 4.03 (1H, d, J ) 4.8 Hz, H-11), 4.55 (1H, br s, H-15),
5.08 and 5.44 (each 1H, br s, H-17), 5.44 (2H, br s, H-2 and
H-3). After four weeks in a NMR tube this compound was
transformed into 19.
7r,15â-Dihydroxy-11â,16â-epoxy-ent-kaur-2,16-diene
(19): 1H NMR (500 MHz, CDCl3) ä 0.90, 0.96, 1.09, and 1.33
(each 3H, s), 1.43 (1H, dt, J ) 12.4 Hz, H-6R), 2.01 (1H, dd, J
) 16.6 and 6 Hz, H-1R), 3.45 (2H, m, H-7 and H-15), 4.24 (1H,
br s, H-11), 5.38 (1H, dd, J ) 10 and 2.5 Hz, H-3), 5.45 (1H,
ddd, J ) 10, 6, and 1.8 Hz, H-2); EIMS m/z (rel int) 318 [M]+
(29), 300 (3), 282 (3), 256 (6), 208 (5).
7â,15â-Dihydroxy-ent-kaur-2,16-dien-19,6-olide (14): col-
orless crystals; 253-255 °C (CHCl3); 1H NMR (500 MHz) ä
0.85 (3H, s, H-20), 1.32 (3H, s, H-18), 1.43 and 2.15 (each 1H,
m, H-12), 1.46 (1H, d, J ) 11.9 Hz, H-14), 1.66 (1H, dd, J )
11.9 and 5.3 Hz, H-14), 1.70 (1H, br d, J ) 16.5 Hz, H-1), 1.96
(1H, dd, J ) 16.5 and 6.4 Hz, H-1), 2.28 (1H, d, J ) 6.5 Hz,
H-5), 2.64 (1H, t, J ) 7 Hz, H-13), 4.42 (1H, d, J ) 6.5 Hz,
H-7), 4.68 (1H, br s, H-15), 4.77 (1H, t, J ) 6.5 Hz, H-6), 5.00
and 5.10 (each 1H, br s, H-17), 5.73 (1H, ddd, J ) 9.8, 6.4,
and 1.6 Hz, H-2), 5.78 (1H, dd, J ) 9.8 and 2.5 Hz, H-3); EIMS
m/z (rel int) 312 [M]+ (58), 284 (41), 269 (15), 240 (19), 235
(17), 207 (8), 195 (16), 169 (16); HREIMS m/z [M]+ 312.1724
(calcd for C20H24O3, 312.1725).
1â,7â,15â-Trihydroxy-ent-kaur-2,16-diene-19-acid (15).
This compound was obtained as the triacetate methyl ester
16a by methylation of the extract and subsequent acetylation
(Ac2O-py; 80 °C, 12 h) and chromatography of the fractions
containing it, eluting with petroleum ether-EtOAc (2:1).
Triacetate methyl ester (16a): a gum; 1H NMR (500 MHz)
ä 1.00 (3H, s, H-20), 1.22 (3H, s, H-18), 1.33 (1H, m, H-14),
1.38 (1H, m, H-11), 1.70 (2H, m, H-11 and H-1), 1.89 (1H, d,
J ) 12 Hz, H-14), 1.96, 2.05 and 2.09 (each 3H, s, -OAc), 2.07
(1H, dd, J ) 9 and 3 Hz, H-5), 2.46 (1H, d, J ) 6.9 Hz, H-9),
2.69 (1H, br s, H-13), 3.61 (3H, s, -OMe), 4.78 (1H, br s, H-7),
4.87 and 4.95 (each 1H, br s, H-17), 5.07 (1H, d, J ) 5.4 Hz,
H-1), 5.45 (1H, br s, H-15), 5.76 (1H, dd, J ) 10.1 and 5.4 Hz,
H-2), 5.88 (1H, d, J ) 10.1 Hz, H-3); EIMS m/z (rel int) 488
[M]+ (0.2), 428 (1), 386 (1), 368 (2), 308 (6), 265 (11), 249 (42),
221 (27), 207 (27), 169 (32); HREIMS m/z [M]+ 488.2425 (calcd
for C27H36O8, 488.2410).
7r,11â,16r-Trihydroxy-15-oxo-ent-(16S)-kaur-2-ene (17):
colorless plates; mp 231-234 °C (petroleum ether-EtOAc);
[R]D -88° (c 0.52, CHCl3); 1H NMR (500 MHz) ä 0.88 (3H, s,
H-19), 0.97 (3H, s, H-18), 1.01 (3H, s, H-20), 1.54 (3H, s, H-17),
1.24 (1H, br s, H-9), 1.33 (1H, dd, J ) 12.4 and 2.0 Hz, H-5),
1.42 (1H, dt, J ) 12.4 Hz, H-6R), 1.69 (1H, d, J ) 16.5 Hz,
H-1), 1.83 (1H, ddd, J ) 12.4, 4.3, and 2.0 Hz, H-6â), 2.05 (2H,
br s, H-12), 2.11 (1H, dd, J ) 16.6 and 4.8 Hz, H-1), 2.29 (1H,
dd, J ) 7 and 4 Hz, H-13), 2.48 (1H, dd, J ) 11.9 and 4.4 Hz,
H-14), 3.96 (1H, d, J ) 4.8 Hz, H-11), 3.99 (1H, dd, J ) 11.6
and 4.2 Hz, H-7), 5.41 (2H, br s, H-2 and H-3); EIMS m/z (rel
int) (334) [M]+ (1), 316 (3), 306 (8), 298 (3), 288 (59), 270 (52),
255 (30), 227 (37), 211 (24); HREIMS m/z [M]+ 334.2137 (calcd
for C20H30O4, 334.2144).
7r,15â,17-Trihydroxy-11â,16â-epoxy-ent-kaur-2-ene (19):
a gum; 1H NMR (500 MHz) ä 0.88 (3H, s, H-19), 0.94 (3H, s,
H-18), 1.08 (3H, s, H-20), 1.24 (1H, br d, J ) 12.8 Hz, H-5),
1.41 (1H, quint, J ) 12.3 Hz, H-6R), 1.55 (1H, br s, H-9), 1.60
(1H, d, J ) 12 Hz, H-14), 1.66 (1H, dd, J ) 12 and 6.4 Hz,
H-14), 1.76 (1H, dd, J ) 12, 4.3, and 1.9 Hz, H-6â), 1.88 (1H,
m, H-12), 2.03 (1H, dd, J ) 16.5 and 5.7 Hz, H-1), 2.13 (1H, d,
J ) 11.4 Hz, H-12), 2.51 (1H, t, J ) 6 Hz, H-13), 3.60 (2H,
complex signal, H-7 and H-15), 3.65 and 3.80 (each 1H, d, J )
11.8 Hz, H-17), 4.32 (1H, br s, H-11), 5.37 (1H, dd, J ) 10 and
2.6 Hz, H-3), 5.43 (1 H, ddd, J ) 10, 6 and 1.4 Hz, H-2); EIMS
m/z (rel int) 334 [M]+ (23), 316 (6), 303 (40), 288 (12), 279 (7),
255 (5), 227 (10), 185 (11); HREIMS m/z [M]+ 334.2152 (calcd
for C20H30O4, 334.2144).
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